MedPath

COMPARISON OF TRANSFORAMINAL EPIDURAL INJECTION OF DEXAMETHASONE AND METHYLPREDNISOLONE IN REDUCING LOW BACK PAIN AND DISABILITY IN PROLAPSED LUMBAR INTERVERTEBRAL DISC

Phase 1
Conditions
Health Condition 1: G544- Lumbosacral root disorders, not elsewhere classified
Registration Number
CTRI/2019/11/021898
Lead Sponsor
Dr Kanti Rajkumari
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with back pain due to prolapsed lumbar disc L4-L5 and L5-S1, confirmed by MRI (Grade II and III), Pain severity with minimum score of 5 based on 10 point scale VAS (Visual Analogue Scale),Pain duration < 3 months, ODI score more than 40, Willingness to comply with treatment and follow-up assessments

Exclusion Criteria

1.Cauda equina syndrome

2.Mental or physical condition that would invalidate evaluation results

3.Prior lumbar surgery at any level

4.Patient is scheduled to have more than one level of steroid injection

5.Pregnancy

6.Systemic or local infection at site of injection

7.Known allergy to corticosteroids, contrast dye or anesthetics

8.History of any malignancy (including hematologic and non-hematologic malignancies)

9.Bleeding disorders

10.Uncontrolled diabetes mellitus/ hypertension

11.Received any spinal injection in the past 3 months

12.Subjects who refused to sign informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Visual Analogue Scale(VAS) <br/ ><br>2. Oswestry Disability Index(ODI) <br/ ><br>Timepoint: 1 week, 1 month, 6 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
SLRTTimepoint: 1 week, 1 month, 6 months
© Copyright 2025. All Rights Reserved by MedPath